Featured Entrepreneurs

Since 2010, MassChallenge has accelerated 2,458 startups that have raised more than $6.2 billion in funding, generated more than $3+ billion in revenue, and created more than 157,000 total jobs. 

Our startups

Be inspired. Search our startups.


Versantis is a pharmaceutical company developing an innovative drug capture platform to treat life-threatening intoxications. This liposomal system will lead to disruptive drugs in a broad range of indications of high unmet need. Built on a de-risked lead candidate with an orphan status (VS-01) , a lean development and regulatory path, and a qualified management team, Versantis will commercialize in 5 years the first drug to save patients with acute liver disease whose mortality rate is >50%.
Versantis is a clinical stage pharmaceutical company developing products of high unmet medical need in the field of liver disease.

Connect with Versantis


2016 Diamond Switzerland

Sub industry


Additional Industries
Healthcare Delivery


MassChallenge strengthens the global innovation ecosystem by accelerating high-potential startups across all industries, from anywhere in the world.